+1(781)975-1541
support-global@metwarebio.com

Lipid Structural Composition Analysis in Lipidomics: Understanding Average Chain Length (ACL) and Unsaturation (ADU)

Lipidomics seeks to comprehensively profile the lipid constituents of biological systems and to quantify how lipid compositions shift in response to physiology, pathology, or experimental perturbations. In high-throughput, mass spectrometry–based lipidomics, ‘Average Chain Length (ACL)’ and ‘Average Degree of Unsaturation (ADU)’ are widely used summary indices that capture global trends in acyl-chain architecture within a defined lipid set. Because acyl-chain length and unsaturation strongly influence membrane packing, bilayer fluidity, curvature stress, and oxidative susceptibility, ACL and ADU are particularly useful for describing lipid remodeling and for enabling robust comparisons across experimental groups (e.g., diet interventions, disease models, drug treatments) [1,2].

 

Definitions and Core Equations for ACL and ADU

ACL and ADU are most commonly computed as abundance-weighted means across a specified lipid collection—typically within a single lipid class (e.g., PC, PE, TG)—to ensure that the resulting indices reflect biologically meaningful variation rather than class-mixing artifacts [3].

1) Average Chain Length (ACL)

ACL = [Σi (Ci × Ai)] / [Σi Ai]

Ci: total number of carbon atoms contributed by acyl chains in lipid species (i)

Example: PC(16:0/18:1) → (Ci = 16 + 18 = 34)

Ai: abundance of lipid species (i) (e.g., peak area or intensity), ideally normalized within the same lipid class prior to calculation

ACL represents the abundance-weighted average carbon number and provides a concise measure of whether a lipid class is dominated by shorter vs. longer acyl-chain compositions.

2) Average Degree of Unsaturation (ADU)

ADU = [Σi (Ui × Ai)] / [Σi Ai]

Ui: total number of double bonds in lipid species (i)

Example: PC(16:0/18:1) → (Ui = 0 + 1 = 1)

Ai: abundance of lipid species (i), treated identically to the ACL calculation

ADU summarizes the abundance-weighted average number of double bonds and is commonly used as a proxy for overall lipid unsaturation within a class.

Practical recommendation: Compute ACL and ADU separately by lipid class (e.g., PC-only, PE-only), because classes differ substantially in backbone chemistry, typical acyl distributions, and biological function. Pooling across classes may obscure class-specific remodeling and complicate interpretation.

 

How to Calculate ACL and ADU: A Practical Workflow

1) Lipid Identification and Quantification

Perform lipid identification and quantification using established software workflows (e.g., LipidSearch, MS-DIAL, LipidXplorer, or equivalent pipelines), generating an output table that includes: lipid annotation (species name), lipid class, total carbon number (C) and total double bonds (U) or sufficient information to derive them, quantitative abundance (peak area/intensity), ideally across all samples and conditions.

2) Structural Parsing and Standardization

Depending on annotation depth, lipids may be reported as:

sum composition (e.g., PC(34:1)), or acyl-resolved composition (e.g., PC(16:0/18:1) or PC(16:0_18:1)).

Both formats are suitable for ACL/ADU as long as:

total carbon number (Ci) and total double bonds (Ui) are correctly derived, and the same annotation rules are applied consistently across all samples.

When annotations are at the sum-composition level, ACL/ADU remain valid class-level descriptors; however, they will not capture positional isomers or differences in acyl pairing (which may be relevant for mechanistic interpretation).

3) Abundance-Weighted Computation

For each lipid class and each sample (or group average), compute:

  • ACL using (Ci) and (Ai),
  • ADU using (Ui) and (Ai).

To improve comparability:

normalize abundances within each class (e.g., total PC abundance = 100% for each sample), or use internal standard–normalized absolute abundances, provided the quantification strategy is consistent.

4) Statistical Testing and Visualization

Common analytical approaches include:

Group comparisons using t-tests, Mann–Whitney U tests, or ANOVA/linear models, depending on design and distributional assumptions;

Visualization via boxplots/violin plots (ACL or ADU per group), scatter plots (ACL vs. ADU), or heatmaps summarizing class-level ACL/ADU across multiple tissues or time points.

Where possible, report effect sizes and confidence intervals in addition to p-values to improve interpretability.

 

Worked Example: Mouse Liver PC Lipids (ND vs. HFD)

Example 1: Phosphatidylcholine (PC)

Lipid species

 Class

C

U

ND abundance

HFD abundance

PC(32:0)

PC

32

0

5.2

2.1

PC(34:1)

PC

34

1

12.8

8.7

PC(36:2)

PC

36

2

20.1

31.5

PC(38:4)

PC

38

4

8.9

15.3

PC(40:6)

PC

40

6

3

7.4

Total

50

65

Abundance values represent relative signal (e.g., normalized peak areas). For ACL/ADU, class-level normalization is recommended (e.g., scaling total PC to 100% per sample), but the weighted-mean logic remains the same if scaling is applied consistently.

Computed indices:

Group

ACL (carbons)

ADU (double bonds)

ND

35.6

2.1

HFD

36.8

2.9

Interpretation: Relative to the normal diet (ND) group, the high-fat diet (HFD) group shows higher ACL and higher ADU within the PC class, indicating a shift toward longer and more unsaturated PC species. Biophysically, increased unsaturation generally promotes greater membrane fluidity and reduces acyl-chain packing density, whereas longer chains can increase hydrophobic thickness and influence bilayer organization. From a redox perspective, enrichment of polyunsaturated species may also elevate susceptibility to lipid peroxidation, which is often relevant in metabolic stress contexts.

Example 2: Demonstration Using a Mixed Lipid Set (Method Illustration)

Lipid (annotation)

Relative content (%)

Fatty-acyl composition

Total carbons (C)

Total double bonds (U)

PC(16:0/18:1)

35.2

16:0,18:1

34

1

PE(18:0/18:2)

22.7

18:0,18:2

36

2

TAG(16:0/18:1/18:3)

18.5

16:0,18:1,18:3

52

4

SM(16:0)

14.3

16:00

16

0

FA(18:3)

9.3

18:03

18

3

ACL calculation

Weighted carbon sum:

(35.2×34)+(22.7×36)+(18.5×52)+(14.3×16)+(9.3×18) =1196.8+817.2+962.0+228.8+167.4=3372.2=1196.8+817.2+962.0+228.8+167.4=3372.2=1196.8+817.2+962.0+228.8+167.4=3372.2

Total abundance:

35.2+22.7+18.5+14.3+9.3=100

ACL=3372.2/100=33.72

Interpretation: The mixture exhibits an average chain length of ~33.72 carbons, consistent with a composition dominated by medium-to-long acyl-chain lipids.

ADU calculation

Weighted double-bond sum:

(35.2×1)+(22.7×2)+(18.5×4)+(14.3×0)+(9.3×3)

=35.2+45.4+74.0+0+27.9=182.5

ADU=182.5/100=1.83

Interpretation: An ADU of ~1.83 indicates a substantial contribution from unsaturated species, which would generally be expected to increase fluidity relative to a more saturated lipid mixture.

Methodological note: This mixed-class demonstration is useful for illustrating calculations, but in practice it is preferable to compute ACL/ADU within each lipid class to preserve biological interpretability.

 

Best Practices for Reporting ACL/ADU in Lipidomics Studies

Avoid cross-class aggregation for inference: Lipid classes differ in backbone structure and typical acyl distributions; class-wise ACL/ADU are more interpretable and less confounded.

Normalization strategy matters:

  • For composition-focused interpretation, normalize within each class (e.g., total PC = 100% per sample);
  • For abundance-focused interpretation, use internal standard–normalized absolute abundances if available, and interpret ACL/ADU alongside total class abundance.
  • Handle missingness and low-confidence IDs carefully: Exclude features with poor identification confidence or excessive missingness, and document filtering thresholds.

Enhancements for deeper interpretation:

Saturation index or PUFA fraction to complement ADU, diversity measures (e.g., Shannon entropy within a class) to quantify distributional broadening/narrowing, integration with pathway-level interpretation (e.g., glycerophospholipid metabolism, desaturase/elongase activity) when mechanistic inference is required.

 

References

1. Palmgren H, Petkevicius K, Bartesaghi S, Ahnmark A, Ruiz M, Nilsson R, Löfgren L, Glover MS, Andréasson AC, Andersson L, Becquart C, Kurczy M, Kull B, Wallin S, Karlsson D, Hess S, Maresca M, Bohlooly-Y M, Peng XR, Pilon M. Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling. Diabetes. 2023 Oct 1;72(10):1350-1363. doi: 10.2337/db22-0293.

2. Perna M, Hewlings S. Saturated Fatty Acid Chain Length and Risk of Cardiovascular Disease: A Systematic Review. Nutrients. 2022 Dec 21;15(1):30. doi: 10.3390/nu15010030.

3. Rawicz W, Olbrich KC, McIntosh T, Needham D, Evans E. Effect of chain length and unsaturation on elasticity of lipid bilayers. Biophys J. 2000 Jul;79(1):328-39. doi: 10.1016/S0006-3495(00)76295-3.

 

Read more

Contact Us
Name can't be empty
Email error!
Message can't be empty
CONTACT FOR DEMO

Next-Generation Omics Solutions:
Proteomics & Metabolomics

Have a project in mind? Tell us about your research, and our team will design a customized proteomics or metabolomics plan to support your goals.
Ready to get started? Submit your inquiry or contact us at support-global@metwarebio.com.
Name can't be empty
Email error!
Message can't be empty
CONTACT FOR DEMO
+1(781)975-1541
LET'S STAY IN TOUCH
submit
Copyright © 2025 Metware Biotechnology Inc. All Rights Reserved.
support-global@metwarebio.com +1(781)975-1541
8A Henshaw Street, Woburn, MA 01801
Contact Us Now
Name can't be empty
Email error!
Message can't be empty
support-global@metwarebio.com +1(781)975-1541
8A Henshaw Street, Woburn, MA 01801
Register Now
Name can't be empty
Email error!
Message can't be empty